Our present results are thus consistent with previous findings suggesting that RASA4 may cooperatively interact with RAS and HIF-1α to inhibit HeLa cell proliferation and abrogate the cytotoxic T-lymphocytes’ ability to kill tumor cells [24]. The gene discussed is HIF1A; the disease is neoplasm.